Article info
PDFCase report
Subcutaneous dexmedetomidine for baclofen withdrawal during palliative sedation
- Correspondence to Dr Jean-Philippe Laroche, Hôpital de la Cité-de-la-Santé, Laval, QC H7M 3L9, Canada; dr.laroche{at}protonmail.com
Citation
Subcutaneous dexmedetomidine for baclofen withdrawal during palliative sedation
Publication history
- Received November 8, 2018
- Revision received November 16, 2018
- Accepted December 19, 2018
- First published January 12, 2019.
Online issue publication
February 19, 2020
Article Versions
- Previous version (19 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.